companydata.dkSCANPHARM A/S: Financial statements 2018
CVR: 16279099
SCANPHARM A/S (CVR 16279099) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 19,563,917 and a net result of DKK -2,876,360 compared with DKK -228,236 the year before. That is an increase of 2.6% compared with the year before. Equity amounted to DKK 9,867,009. The solvency ratio was 25.8%. The company had 46 employees in the financial year.
- Gross Profit
- 19,563,917 kr.
- Profit/Loss
- -2,876,360 kr.
- Equity
- 9,867,009 kr.
- Total Assets
- 38,186,386 kr.
- Employees
- 46
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | 19.6 mio. | -2.9 mio. | 9.9 mio. | 46 |
| 2017 | - | 19.1 mio. | -228 t. | 12.7 mio. | 43 |
| 2016 | - | 19.6 mio. | 1.3 mio. | 13 mio. | 42 |
| 2015 | - | 20.4 mio. | 716 t. | 11.7 mio. | 42 |
| 2014 | - | 20.8 mio. | 431 t. | 11 mio. | - |
Keep an eye on SCANPHARM A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2018
SCANPHARM A/S has published its annual report for 2017. Gross profit came to DKK 19,072,265, and the net result was DKK -228,236.
As of January 30, 2018, Rolf Eckersberg is registered as director of SCANPHARM A/S.
As of January 30, 2018, Ole Bjørn Jensen has stepped down as director of SCANPHARM A/S.
As of January 22, 2018, Peluli Holding ApS is registered as an owner of SCANPHARM A/S with an ownership share of 10%.
About SCANPHARM A/S
SCANPHARM A/S is a Danish company of the type Aktieselskab based in Birkerød, founded in 1992. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named SCANPHARM A/S AF 1992 and A/S SCANPHARM AF 1992. The management consists of Andreas Bjørn Jensen. The company is owned by CHLOPETHAN A/S and Peluli Holding ApS. The company has 51 employees. In 2025, the company reported a gross profit of DKK 29,716,677 and a net result of DKK 962,722 compared with DKK 582,684 the year before. Equity amounted to DKK 3,045,406.